Noninvasix receives FDA breakthrough device designation for non-invasive monitoring technology for sepsis

23 February 2022 - LIVOx is first monitoring device to non-invasively monitor sepsis by detecting a key indicator of septic ...

Read more →

FDA permits marketing of first condom specifically indicated for anal intercourse

23 February 2022 - Other FDA cleared condoms can continue to be used for contraception and to prevent sexually transmitted infections. ...

Read more →

Medtronic receives FDA approval for InterStim X system, the next generation of the most personalised sacral nerve stimulation therapy for bladder and bowel control

22 December 2022 - New InterStim X system provides 10 to 15 years of battery life without the need to recharge. ...

Read more →

NeuroSigma receives FDA breakthrough device designation for Monarch eTNS system

22 February 2022 - Monarch eTNS recognised as novel device for drug resistant epilepsy. ...

Read more →

Bonalive Biomaterials granted FDA breakthrough device designation for a bone graft substitute that potentially protects against microbial colonisation

16 February 2022 - The Center for Devices and Radiological Health at the U.S. FDA has determined that Bonalive Orthopedics granules, ...

Read more →

3D printing medical devices: stakeholders weigh in on FDA’s discussion paper

15 February 2022 - The US FDA has started thinking about how 3D printing of medical devices at the point ...

Read more →

Foundation Medicine’s ctDNA monitoring assay, FoundationOne Tracker, granted breakthrough device designation by U.S. Food and Drug Administration

15 February 2022 - Foundation Medicine today announced that the U.S. FDA has granted a breakthrough device designation for its circulating ...

Read more →

Cardiosense receives FDA breakthrough device designation for algorithm to identify patients at risk of decompensated heart failure

15 February 2022 - Cardiosense announced today that the U.S. FDA has granted the company breakthrough device status for its ...

Read more →

Rapid Medical receives FDA breakthrough device designation for vasospasm treatment

15 February 2022 - Comaneci temporarily expands blood vessels, recognised as novel device for life-threatening disease. ...

Read more →

Theradaptive wins additional FDA breakthrough designation for spinal fusion

15 February 2022 - Theradaptive announced that the U.S. FDA has granted breakthrough medical device designation for its OsteoAdapt SP Spinal ...

Read more →

To hell and back: devices meant to ease pain are causing trauma

5 February 2022 - A $35,000 treatment at the forefront of medical technology which pumps electric pulses into the spine ...

Read more →

BioCardia receives FDA breakthrough device designation for CardiAMP cell therapy system for heart failure

3 February 2022 - BioCardia today announced that the U.S. FDA has granted breakthrough device designation for the CardiAMP Cell ...

Read more →

Aussie device that gives eyes to the blind fast tracked in US

1 February 2022 - A world-first bionic eye that restores partial vision to the blind has been given “breakthrough” designation ...

Read more →

Blue Note Therapeutics receives breakthrough device designation for prescription only digital therapeutic for acute myeloid leukaemia

31 January 2022 - Blue Note Therapeutics, a prescription digital therapeutics company dedicated to easing the burden of cancer and improving ...

Read more →

Applaud Medical receives FDA breakthrough device designation for the company’s acoustic enhancer for use in conjunction with ureteroscopy with laser lithotripsy for the fragmentation of calcium based kidney stones

31 January 2022 - Applaud Medical today announced that its acoustic enhancer technology has received breakthrough device designation from the U.S. ...

Read more →